Skip to main content
SpringerLink
Log in

Neuroprotection in Ischemic/Hypoxic Disorders

From the Preclinical to the Clinical Testing

  • Conference paper
Frontiers in Clinical Neuroscience

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 541))

Abstract

In the brain, the most common lesion is ischemic and/or hypoxic by origin. The insult results in neuronal loss. The primary aim of therapeutic interventions to reduce the volume of brain damage and thus, to lessen the neurological impairment, disability and handicap among stroke survivors. Reduction in infarct size may also reduce the risk of early death, particularly due to ischemic cerebral edema and transtentorial herniation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Y. Li, M. Chopp, N. Jiang, C. Zaloga, In situ detection of DNA fragmentation after focal cerebral ischemia in mice, Brain Res Mol Brain Res 28, 164–168 (1995).

    Article  PubMed  CAS  Google Scholar 

  2. Y.Li, M. Chopp, N. Jiang, Z.H. Zang, C. Zaloga, Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats, Stroke 26, 1252–1258 (1995).

    Article  PubMed  CAS  Google Scholar 

  3. M. Chopp, Y. Li, and Z.G. Zhang, Protein Expression and brain plasticity after transient middle Cerebral Artery Occlusion in the rat, In: Maturation Phenomenon in Cerebral Ischemia II./Springer (1998).

    Google Scholar 

  4. K. Matsushita, T. Matsuyama, K. Kitagawa, M. Matsumoto, T. Yanagihara, M. Sugita, Alternations of Bcl-2 family proteins precede cytoskeletal proteolysis in the penumbra, but not in infarct centers following focal celebrai ischemia in mice, Neuroscience 83, 439–448 (1998).

    Article  PubMed  CAS  Google Scholar 

  5. J. Chen, S.H. Graham, P.H. Chan, J. Lan, R.L. Zhou, R.P. Simon, Bcl-2 in expressed in neurons that survive focal ischemia in the rat, Neuroreport 6, 394–398 (1995).

    Article  PubMed  CAS  Google Scholar 

  6. M. Asahi, M. Hoshimaru, Y. Uemura, T. Tokime, M. Kojima, T. Ohtsuka, N. Matsura, T. Aoki, K. Shibahara, H. Kikuchi, Expression of interleukin-1 beta converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery, J. Cereb Blood Flow Metab 17, 11–18 (1997).

    Article  PubMed  CAS  Google Scholar 

  7. S. Namura, J. Zhu, K. Fink, M. Endres, A. Srinivasan, K.J. Tomaselli, J. Yuan, M.A. Moskowith, Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia, J Neurosci 18, 3659–3668 (1998).

    PubMed  CAS  Google Scholar 

  8. G.Y. Yang, C. Gong, Z. Qin, W. Ye, Y. Mao, A.L. Bertz, Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice, Brain Res Mol Brain Res 69, 135–143 (1999).

    Article  PubMed  CAS  Google Scholar 

  9. H. Nawashiro, D. Martin, J.M. Hallenbeck, Inhibition of tumor necrosis factor and amelioration of brain infarction in mice, J Cereb Blood Flow Metab 17, 229–232 (1997).

    Article  PubMed  CAS  Google Scholar 

  10. M.P. Mattson, Neuroprotective signal transduction: relevance to stroke, Neurosci Biobehav Rev 21, 193–206 (1997).

    Article  PubMed  CAS  Google Scholar 

  11. X. Shi, M. Ding, Z. Dong, F. Chen, J. Ye, S. Wang, S.S. Leonard, V. Castranova, V. Vallyathan, Antioxidant properties of aspirin: characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-kappaB activation, and TNF-alpha production, Mol Cell Biochem 199, 93–102.(1999).

    Article  PubMed  CAS  Google Scholar 

  12. M.A. Stevenson, M.J. Zhao, A. Asea, C.N. Coleman, S.K. Calderwood, Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein-and NF-kappa B-responsive genes, J. Immunol 163, 5608–5616 (1999).

    PubMed  CAS  Google Scholar 

  13. K.K.W. Wang, Calpain and caspase: can you tell the difference? TINS No 1, 23, 20–26 (2000).

    PubMed  Google Scholar 

  14. J.S. Kim, S.C. Gautam, M. Chopp, C. Zaloga, M.L. Jones, P.A. Ward, K.M. Welch, Expression of monocyte chemoattractabt protein-1 and macrophage3 inflammatory protein-1 after focal cerebral ischemia in the rat, J Neuroimmunol 56, 127–134 (1995).

    Article  PubMed  CAS  Google Scholar 

  15. I.S. Moon, M.L. Apperson, and M.B. Kennedy, The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl D-aspartate receptor subunit 2B, Proc.Natl.Acad.Sci. 91, 3954–3958 (1994).

    Article  PubMed  CAS  Google Scholar 

  16. J.P. Mohr, J.M. Orgogozo, M.J.G. Harrison, N.G. Wahlgren, J.H. Gelmers, E. Martinez-Vila, J. Dycka, D. Tettenborn, Meta-analysis of oral nimodipine trials in acute ischaemic stroke Cerebrovasc Dis. 4, 197–203 (1994).

    Article  Google Scholar 

  17. N.G. Wahlgren, Cytoprotective therapy for acute ischaemic stroke, In: M. Fisher, (ed.) Stroke Therapy, Butterworth and Heinemann, Boston, pp. 315–350. (1995).

    Google Scholar 

  18. N.G. Wahlgren, A Review of earlier clinical studies on neuroprotective agents and current approaches. Neuroprotective agents and cerebral ischeamia, International Review of Neurobiology 40, 337–353. (1997).

    Article  PubMed  CAS  Google Scholar 

  19. X. Xie, B. Lancaster, T. Peakman, and J. Garthwaite, Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hyppocampal neurones, Pflügers Arch 430, 437–446 (1995).

    Article  PubMed  CAS  Google Scholar 

  20. J.S. Beckman, Nitric oxide, Superoxide and perosynitrite in CNS injury, Cerebrovascular Diseases pp:209–210. (1997).

    Google Scholar 

  21. S.A Lipton, and J.S. Stamler, Actions of redoxrelated congeners of nitric oxide at the NMDA receptor, Neuropharmacology 33, 1229–1233 (1994).

    Article  PubMed  CAS  Google Scholar 

  22. C. Iadecola, Bright and dark sides of nitric oxide in ischemic brain injury, Trends Neurosci 20, 132–139 (1997).

    Article  PubMed  CAS  Google Scholar 

  23. U. DirnagL C. Iadecola, M.A. Moskowitz, Pathobiology of ischemic stroke: an integrated view, Trends Neurosci 22, 391–397. (1999).

    Article  PubMed  Google Scholar 

  24. Z. Huang, P.L, Huang, N. Panahian, T. Dalkara, M.C. Fishman, M.A. Moskowitz, Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase, Science 265, 1883–1885 (1994).

    Article  PubMed  CAS  Google Scholar 

  25. M. Nagayama, K. Niwa, T. Nagayama, M.E. Ross, C.Iadecola, The cyclooxygenase-2 inhibitor NS-389 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene, J Cereb Blood Flow Metab 19, 1213–1219 (1999).

    Article  PubMed  CAS  Google Scholar 

  26. P. Marin, K.L. Nastiuk, N. Daniel, J.A. Girault, A.J. Czemik, J. Glowinski, A.C. Nairn, J. Premont, Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons, J Neurosci 17, 3445–3454 (1997).

    PubMed  CAS  Google Scholar 

  27. C. Iadecola, F. Zhang, R. Casey, H.B. Clark, M.E. Ross, Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia Stroke 27, 1371–1380 (1996).

    Article  Google Scholar 

  28. G.Y. Yang, C. Gong, Z. Qin, W. Ye, Y. Mao, A.L. Bertz, Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice, Brain Res Mol Brain Res 69, 135–143 (1999).

    Article  PubMed  CAS  Google Scholar 

  29. M. Vastag, J. Skopál, Z. Voko, É. Csonka, Z. Nagy, Expression of Membrane-bound and soluble cell adhesion molecules by human brain microvessel endothelial cells. Microvascular Research 57, 52–60. (1999).

    Article  PubMed  CAS  Google Scholar 

  30. Y. Li, M. Chopp, Z.G. Zhang, R.L. Zhang, J.H. Garcia, Neuronal survival is associated with 72-kDA heat shock protein expression after transient middle cerebral artery occlusion in the rat, J. Neurol Sci 120, 187–194 (1993).

    Article  PubMed  CAS  Google Scholar 

  31. M. Chopp, Y. Li, N. Jiang, R.L. Zhang, J. Prostak, Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain, J Cereb Blood Flow Metab 16, 578–587 (1996).

    Article  PubMed  CAS  Google Scholar 

  32. Zhang, R.L., Zhang, Z.G., Chopp, M., Zivin, J.A. (1999) Thrombolysis weith tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain. Stroke, 30, 624–629.

    Article  PubMed  CAS  Google Scholar 

  33. S. Mun-Bryce, G.A. Rosenberg, Matrix melloproteinases in cerebrovascular disease, J Cereb Blood Flow Metab 18, 1163–1172 (1998).

    Article  PubMed  CAS  Google Scholar 

  34. Y. Gasche, M. Fujimura, Y. Morita-Fujimura, J.C. Copin, M. Kawase, J. Massengale, P.H. Chan, Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction, J Cereb Blood Flow Metab 19, 1020–1028 (1999).

    Article  PubMed  CAS  Google Scholar 

  35. J.H. Heo, J. Lucero, T. Abumiya, J.A. Koziol, B.R. Copeland, G.J. del Zoppo, Matrix metalloproteinases increase very early during experimental focal cerebral ischemia, J Cereb Blood Metab 19, 624–633 (1999).

    Article  CAS  Google Scholar 

  36. R. Bravo Growth factor responsive genes in fibroblasts, Cell Growth Diff. 1, 305–309 (1990).

    PubMed  CAS  Google Scholar 

  37. P.J. Lindsberg, K.U. Frerichs, A.L. Siren, J.M. Hallenbeck, T.S. Nowak, Jr. Heat-shock protein and C-fos expression in focal microvascular brain damage, J Cereb Blood Flow Metab 16, 82–91 (1996).

    Article  PubMed  CAS  Google Scholar 

  38. J.I. Morgan, and T. Curran, Stimulus-transcription coulping in the nervous system: Involvement of the inducible proto-oncogenes fos an jun, Annu. Rev. Neurosci 14, 421–451 (1991).

    Article  PubMed  CAS  Google Scholar 

  39. K. Matsushima, R. Schmidt-Kastner, M.J. Hogan, A.M. Hakim, Cortical spreading depression activates tropic factor expression in neurons and astrocytes and protects against subsequent focal brain ischemia, Brain Res 807, 47–60 (1998).

    Article  PubMed  CAS  Google Scholar 

  40. T.S. Nowak, M. Kiessling, Reprogramming of gene expression aafter ischemia, In: W. Walz, N.J. Totowa, (eds.) Cerebral Ischemia: Molecular and Cellular Pathophysiology Humana Press, pp. 145–216. (1999).

    Google Scholar 

  41. J.I. Morgan, T. Curran, Immediate-early genes: ten years on, Trends Neurosci 18, 66–67 (1995).

    Article  PubMed  CAS  Google Scholar 

  42. M. Walton, B. Conner, P. Lawlor, D. Young, E. Sirimanne, P. Gluckman, G. Cole, M. Dragunow, Neuronal death and survival in two models of hypoxic-ischaemic brain damage, Brain Res Brain Res Rev 29, 137–168 (1999).

    Article  PubMed  CAS  Google Scholar 

  43. M. Kiessling, G. Stumm, Y. Xie, T. Herdegen, A. Aguzzi, R. Bravo, and P. Gass, Differential transcription and translation of immediate early genes in the gerbil hippocampus after transient global ischemia, J Cereb Blood Flow Metab 13, 914–924 (1993).

    Article  PubMed  CAS  Google Scholar 

  44. C. Sommer, P. Gass, M. Kiessling, Selective c-JUN expression in CA1 neurons of the gerbil hippocampus during and after acquisition of an ischemia-tolerant state, Brain Pathol 5, 135–144. (1995).

    Article  PubMed  CAS  Google Scholar 

  45. T.S.Nowak, Jr. Localization of 70 kDa heat shock protein mRNA following transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 11, 432–439 (1991).

    Article  Google Scholar 

  46. J. Zou, Y. Guo, T. Guettouche, D.F. Smith, R.Voellmy, Repressing of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1, Cell 94, 471–480 (1998).

    Article  PubMed  CAS  Google Scholar 

  47. M.A. Yenari, S.L. Fink, G.H. Sun, L.K. Chang, M.K. Patel, D.M. Kunis, D. Onley, D.Y. Ho, R.M. Sapolsky, G.K. Steinberg, Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy, Ann Neurol 44, 584–591. (1998).

    Article  PubMed  CAS  Google Scholar 

  48. M.J. Wagstaff, J. Smith, Y. Collaco-Moares, J.S. De Belleroche, R. Voellmy, R.S. Coffin, D.S. Latchman, Delivery of a constitutively active form of the heat shock factor using a virus vector protects neural cells from thermal or ischemic stress but not from apoptosis, Suppl Eur J Neurosci 10, 3343–3350. (1998).

    Article  CAS  Google Scholar 

  49. J.C. Plumier, J.N. Armstrong, N.I. Wood, J.M. Babity, T.C. Hamilton, A.J. Huntrer, H.A. Robertson, R.W. Currie, Differential expression of c-fos, Hsp70 and Hsp27 after photothrombic injury in rat brain, Brain Res Mol Brain Res 45, 239–246 (1997).

    Article  PubMed  CAS  Google Scholar 

  50. J. Chen, R. Simon, Ischemic tolerance in the brain, Neurology 48, 306-311.(1997).

    Google Scholar 

  51. M. Bergeron, D.M. Ferriero, H.J. Vreman, D.K. Stevenson, F.R. Sharp, Hypoxia-ischemia, but not hypoxia alone, induces the expression of heme oxygenase-1 (HSP32) in newborn rat brain. J Cereb Blood Flow Metab, 17, 647–658 (1997).

    Article  PubMed  CAS  Google Scholar 

  52. G.L. Semenza, Perspectives on oxygen sensing, Cell 98, 281–284 (1999).

    Article  PubMed  CAS  Google Scholar 

  53. P. Ratcliffe, J. Rourke, P. Maxwell, Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression, J Exp Biol 201, 1153–1162 (1998).

    PubMed  CAS  Google Scholar 

  54. M. Bergeron, A.Z. Yu, K.E. Solway, G.L. Semenza, F.R. Sharp, Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischemia in rat brain, Eur J Neurosci 11, 4159–4170 (1999).

    Article  PubMed  CAS  Google Scholar 

  55. I. Flamme, T. Frohlich, M. von Reutern, A. Kappel, A. Damert, W. Risau, HRF, a putative basic helix-loophelix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels, Mech Dev 63, 51–60 (1997).

    Article  PubMed  CAS  Google Scholar 

  56. Q.H. Zhai, N. Fuell, F.J. Che, Gene expression of IL-10 in relationship to TNF-alpha, IL-lbeta and IL-2 in the rat brain-following middle cerebral artery occlusion, J Neurol Sci 152, 119–124 (1997).

    Article  PubMed  CAS  Google Scholar 

  57. S.A. Loddick, A.V. Turnbull, N.J. Rothwell, Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat, J Cereb Blood Flow Metab 18, 176–179 (1998).

    Article  PubMed  CAS  Google Scholar 

  58. X. Wang, J.A. Ellison, A.L. Siren, P.G. Lysko, T.L. Yue, F.C. Barone, A. Shatzman, G.Z. Feuerstein, Prolonged expression of interferoninducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat, J Neurochem 71, 1194–1204. (1998).

    Article  PubMed  CAS  Google Scholar 

  59. H. Tomimoto, M. Shibata, M. Ihara, I. Akiguchi, R. Ohtani, H. Budka, A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans, Acta Neuropathol 104(6), 601–7 (2002).

    PubMed  CAS  Google Scholar 

  60. M. Nagayama, K. Niwa, T. Nagayama, M.E. Ross, C. Iadecola, The cyclooxygenase-2 inhibitor NS-389 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J Cereb Blood Flow Metab 19, 1213–1219 (1999).

    Article  PubMed  CAS  Google Scholar 

  61. N.S. Levy, M.A. Goldberg, A.P. Levy, Sequencing of the human vascular endothelial growth factor (VEGF) 3’ untranslated region (UTR): conversation of five ypoxia-inducible RNA-protein binding sites, Biochim Biophys Acta 1351, 167–173 (1997).

    Google Scholar 

  62. C.S. Cobbs, J. Shen, D.A. Greenberg, S.H. Graham, Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat, Neurosci Lett 249, 79–82 (1998).

    Article  PubMed  CAS  Google Scholar 

  63. M.M. Valter, A. Hugel, H.J. Huang, W.K. Cavenee, O.D. Wiestler, T. Pietsch, N. Wernert, Expression of the Ets-1 transciption factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-l)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 59, 5608–5614 (1999).

    PubMed  CAS  Google Scholar 

  64. J.C. LaMamma, N.T. Kuo, W.D. Lust, Hypoxia-induced brain angiogenesis. Signals and consequences, Adv. Exp Med Biol 454, 287–293 (1998).

    Article  Google Scholar 

  65. N. van Bruggen, H. Thibodeaux, J.T. Palmer, W.P.P. Lee, LFu, B. Cairns, D. Tumas, R. Gerlai, S.P. Williams, M. van Lookeren Campagne, N. Ferrara, VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injuri in the mouse brain, J Clin Invest 104, 1613–1620 (1999).

    Article  PubMed  Google Scholar 

  66. M. Verheij, R. Bose, X.H. Lin, B. Yao, W.D. Jarvis, S. Grant, M.J. Birrer, E. Szabo, LI. Zon, J.M. Kyriakis, A. Haimovitz-Friedman, Z. Fuks, and R.N. Kolesnick, Requirement for ceramide-initiated SAPK/JNK signalling in stress induced apoptosis Nature 380, 75–79 (1996).

    Article  PubMed  CAS  Google Scholar 

  67. W.H. Lee, G.M. Wang, L.B. Seaman, S.J. Vannucci, Coordinate IGF-I and IGFBP5 gene expression in perinatal rat brain after hypoxia-ischemia J Cereb Blood Flow Metab 16, 227–236 (1996).

    Article  PubMed  CAS  Google Scholar 

  68. M. Fujimura, Y. Gasche, Y. Morita-Fujimura, M. Kawase, P.H. Chan, Early decrease of apurinic/apyrimidinic endonuclease expression after transient focal cerebral ischemia in mice, J Cereb Blood Flow Metab 19, 495–501 (1999).

    Article  PubMed  CAS  Google Scholar 

  69. M. Fujimura, T. Morita-Fujimura Ysugawara, P.H. Chan, Early decrease of XRCCL a DNA base excision repair protein, may contribute to DNA fragmentation after transient focal cerebral ischemia in mice Stroke 30, 2456–2462 (1999).

    Article  PubMed  CAS  Google Scholar 

  70. M. Chopp, Y. Li, and Z.G. Zhang, Protein Expression and brain plasticity after transient middle Cerebral Artery Occlusion in the rat. In: Maturation Phenomenon in Cerebral Ischemia II./Springer(1998).

    Google Scholar 

  71. S.S. Magavi, B.R. Leavitt, J.D. Macklis, Induction of neurogenesis in the neocortex of adult mice, Nature 405(6789), 951–5 (2000).

    Article  PubMed  CAS  Google Scholar 

  72. S.S. Magavi, J.D. Macklis, Induction of neuronal type-specific neurogenesis in the cerebral cortex of adult mice: manipulation of neural precursors in situ, Brain Res Dev Brain Res 134(1-2), 57–76 (2002).

    Article  PubMed  CAS  Google Scholar 

  73. D.J. Gladstone, S.E. Black, A.M. Hakim, Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions, Stroke 33(8), 2123–36 (2002).

    Article  PubMed  Google Scholar 

  74. Z. Nagy, P. Vargha, L. Kovács, P. Bönōczk, Meta-analysis of Cavinton, Praxis 49, 420–4 (1998).

    Google Scholar 

  75. V.L. Feigin, B.M. Doronin, T.F. Popova, E.V. Gribatcheva, D.V.Tchervov, Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial, Eur J Neurol 8(1), 81–5 (2001).

    Article  PubMed  CAS  Google Scholar 

  76. C. Stole, Indole derivativesas neuroprotecrants, Life Sci. 65, 1943–1950 (1999).

    Article  Google Scholar 

  77. M. Miyazaki, The effect of a cerebral vasodilator, vinpocetine, on cerebral vascular resistance evaluated by the Doppler ultrasonic technique in patients with cerebrovascular diseases, Angiology 46(1), 53–8 (1995).

    Article  PubMed  CAS  Google Scholar 

  78. N. Miyata, H. Yamaura, M. Tanaka, M. Muramatsu, K. Tsuchida, S. Okuyama, S. Otomo, Effects of VA-045, a novel apovincaminic acid derivative, on isolated blood vessels: cerebroarterial selectivity, Life Sci 52(18), PL181-6 (1993).

    Google Scholar 

  79. V. Lakics, P. Molnar, S.L. Erdo, Protection against veratridine toxicity in rat cortical cultures: relationship to sodium channel blockade. Neuroreport 7(1), 89–92 (1995).

    PubMed  CAS  Google Scholar 

  80. V. Lakics, M.G. Sebestyen, S.L. Erdo, Vinpocetine is a highly potent neuroprotectant against veratridine-induced cell death in primary cultures of rat cerebral cortex, Neurosci Lett 185(2), 127–30 (1995).

    Article  PubMed  CAS  Google Scholar 

  81. K. Ishihara, H. Katsuki, M. Sugimura, M. Satoh, Idebenone and vinpocetine augment long-term potentiation in hippocampal slices in the guinea pig, Neuropharmacology 28(6), 569–73 (1989).

    Article  PubMed  CAS  Google Scholar 

  82. S. Kaneko, H. Takahashi, M. Satoh, The use of Xenopus oocytes to evaluate drugs affecting brain Ca2+ channels: effects of bifemelane and several nootropic agents, Eur J Pharmacol 189(1), 51–8 (1990).

    Article  PubMed  CAS  Google Scholar 

  83. P. Molnar, S.L. Erdo, Vinpocetine is as potent as phenytoin to block voltage-gated Na+ channels in rat cortical neurons, Eur J Pharmacol 273(3), 303–6 (1995).

    Article  PubMed  CAS  Google Scholar 

  84. L. Tretter, V. Actam-Vizi, The neuroprotective drug vinpocetine prevents veratridine-induced [Na+]i and [Ca2+]i rise in synaptosomes, Neuroreport 9(8), 1849–53 (1998).

    Article  PubMed  CAS  Google Scholar 

  85. T. Zelles, L. Franklin, I. Koncz, B. Lendvai, G. Zsilla, The nootropic drug vinpocetine inhibits veratridine-induced [Ca2+]i increase in rat hippocampal CA1 pyramidal cells, Neurochem Res 26(8-9):1095–100 (2001).

    Article  PubMed  CAS  Google Scholar 

  86. M.S. Santos, A.I. Duarte, P.I. Moreira, C.R. Oliveira, Synaptosomal response to oxidative stress: effect of vinpocetine, Free Radic. Res. 32(l):57–66 (2000).

    Article  PubMed  CAS  Google Scholar 

  87. G.A. King, Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice, Arch.Int.Pharmacodyn. Ther. 286, 299–307 (1987).

    PubMed  CAS  Google Scholar 

  88. M. Yamamoto, M. Shimizu, S. Kawabata, Cerebral vasodilators potentiate the anti-anoxic activity of indeloxazine hydrochloride, a new cerebral activator, Neuropharmacology 28, 313–317 (1989).

    Article  PubMed  CAS  Google Scholar 

  89. H. Hara, A. Ozaki, M.S.T. Yoshidomi, Protective effect of KB-2796, a new calcium antagonist, in cerebral hypoxia and ischemia, Arch. Int. Pharmacodyn. Ther. 304, 206–218 (1990).

    PubMed  CAS  Google Scholar 

  90. J.C. Lamar, M. Beaughard, C. Bromont, H. Pignet, Effects of vinpocetine in four pharmacological models of cerebral ischemia, In: Krieglstein J ed. Pharmacology of cerebral ischemia. Amsterdam: Elsevier, pp 334–339 (1986).

    Google Scholar 

  91. K Yamaguchi, S. Yamada, M. Yoshida, K. Kyuki, S. Okuyama, Anti-anoxic effects of VA-045, J. Pharmacol. 61 (suppl. 1),184 (1993).

    Google Scholar 

  92. S. Takeo, K. Tanonaka, T. Hirano, T. Miyake, J. Okamoto, Cerebroprotective action of naftidrofuryl oxalate I:prolongation of survival time and protection of cerebral energy metabolism in bilateral carotid artery ligated mice, Folia Pharmacol. Japon. 91, 267–273 (1988).

    Article  CAS  Google Scholar 

  93. V. Vaizov, T.M. Plotnikova, T. Yakimova, O. Vaizova, A. Saratikov, Ammonium succinate: An effective corrector of circulatory cerebral hypoxia, Byull. Eksp. Biol.Med. 118, 276–278 (1995).

    Google Scholar 

  94. V.J. DeNoble, Vinpocetine enhances retrieval of a step-through passive avoidance response in rats, Pharmacol. Biochem. Behav. 26, 183–186 (1987).

    Article  Google Scholar 

  95. D. Groó, E. Pálosi, L. Szporny, Effect of vinpocetine in scopolamine-induced learning and memory impairments, Drug Dev. Res. 11, 29–36 (1987).

    Article  Google Scholar 

  96. D. Groó, E. Pálosi, L. Szporny, Comparison of the effects of vinpocetine, vincamine, and nicergoline on the normal and hypoxia-damaged learning process in spontaneously hypertensive rats, Drug Dev.Res. 15, 75–85 (1988).

    Article  Google Scholar 

  97. D. Groó, E. Pál osi, L. Szporny, Effect of vinpocetine in memory disturbances induced by different damaging agents, In: Krieglstein J, ed. Pharmacology of cerebral ischemia. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 229–305.

    Google Scholar 

  98. C. Backhaus, C Karkoutly, M. Welsch, J. Krieglstein, A mouse model of focal cerebral ischemia for screening neuroprotective drug effects, J. Pharmacol. Toxicol.Meth. 27, 27–32 (1992).

    Article  Google Scholar 

  99. G. Bielenberg, Effects of vincamine and vinpocetine on infarct size in focal cerebral ischemia, Arch Pharmacol 354 (suppl. 1):R122, (1992).

    Google Scholar 

  100. R. Rischke, J. Krieglstein, Increased LCGU and decreased LCBF in rat hippocampus 7 days after ischemia, J Neurochem. 52(suppl S56), (1989).

    Google Scholar 

  101. R. Rischke, J. Krieglstein, Effects of vinpocetine on local cerebral blood flow and glucose utilization seven days after forebrain ischemia in the rat, Pharmacology 41, 153–160 (1990).

    Article  PubMed  CAS  Google Scholar 

  102. R. Rischke, J. Krieglstein, Protective effect of vinpocetine against brain damage caused by ischemia, Jpn. J. Pharmacol. 56, 349–356 (1991).

    Article  PubMed  CAS  Google Scholar 

  103. T. Araki, K. Kogure, K. Nishioka, Comparative neuroprotective effects of pentobarbital, vinpocetine, flunarizine and ifenprodil on ischemic neuronal damage in the gerbil hippocampus, Res. Exp.Med. (Berl.) 190, 19–23 (1990).

    Article  CAS  Google Scholar 

  104. K. Kogure, H. Kato, Pharmacological modification of post-ischemic brain cell injury, Clin. Neuropharmacol. 13(suppl. 2), 154–155 (1990).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Vascular Neurology, Semmelweis University, Budapest, Hungary

    Zoltán Nagy & László Simon

Authors
  1. Zoltán Nagy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. László Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Szeged, Szeged, Hungary

    László Vécsei

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this paper

Cite this paper

Nagy, Z., Simon, L. (2004). Neuroprotection in Ischemic/Hypoxic Disorders. In: Vécsei, L. (eds) Frontiers in Clinical Neuroscience. Advances in Experimental Medicine and Biology, vol 541. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8969-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-8969-7_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4740-8

  • Online ISBN: 978-1-4419-8969-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation